James A. Robinson Jr.
Board Member
UroGen Pharma Ltd. (URGN)Equibles does not estimate personal net worth.
About James A. Robinson Jr.
James A. Robinson Jr. is recorded as Board Member at UroGen Pharma Ltd. (URGN) since July 25, 2023. UroGen Pharma Ltd. reported in an 8-K filed July 25, 2023 that James A. Robinson Jr. was appointed director, effective July 25, 2023. UroGen Pharma Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at UroGen Pharma Ltd. includes Elizabeth Barrett (CEO and Board Member), Arie Belldegrun (Chairman and Board Member), Chris Degnan (CFO) and 7 others.
“On July 25, 2023, the board of directors (the “Board”) of UroGen Pharma Ltd., an Israeli company (the “Company”), at the recommendation of the Nominating and Corporate Governance Committee, increased the size of the Board from eight to nine directors, appointed James A. Robinson Jr. to fill the vacancy on the Board and to hold office until the Company’s 2023 Annual Meeting of Shareholders, and also appointed Mr. Robinson to the Compliance Committee of the Board.”
Affiliation history
-
Current
2023-07-25–present
Company network
Leadership on record at UroGen Pharma Ltd.
- Elizabeth Barrett CEO, Board Member
- Arie Belldegrun Chairman, Board Member
- Chris Degnan CFO
- Dong (Don) Kim CFO
- Stephen L. Mullennix COO
- Jason Smith General Counsel
- Christopher Degnan Chief Accounting Officer
- Arie Belldegrun, M.D. Board Member
- Arie Belldegrun, M.D., FACS Board Member
- Cynthia M. Butitta Board Member